UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Diagnosis and follow up of aortitis in the elderly

Annals of the rheumatic diseases, 2004-11, Vol.63 (11), p.1507-1510

2004

Link zum Volltext

Verfügbarkeit prüfen

Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter

Experimental and clinical endocrinology & diabetes, 2006-05, Vol.114 (5), p.235

2006

Link zum Volltext

Verfügbarkeit prüfen

Expression of the sodium iodide symporter in differentiated thyroid cancer: clinical evidence

Nuclear medicine, 2005, Vol.44 (3), p.86

2005

Link zum Volltext

Verfügbarkeit prüfen

Quantitative thyroid scintigraphy for the differentiation of Graves' disease and hyperthyroid autoimmune thyroiditis

Nuclear medicine, 2004, Vol.43 (4), p.124

2004

Link zum Volltext

Verfügbarkeit prüfen

Improvement of tomographic reconstruction in bone SPECT

Nuclear medicine, 2006, Vol.45 (1), p.35

2006

Link zum Volltext

Verfügbarkeit prüfen

F-18-FDG hybrid camera PET in patients with postoperative fever

Nuclear medicine, 2002-02, Vol.41 (1), p.22

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma

Nuclear medicine, 2003, Vol.42 (2), p.71

2003

Link zum Volltext

Verfügbarkeit prüfen

Chronic bacterial osteomyelitis: prospective comparison of 18F-FDG imaging with a dual-head coincidence camera and 111In-labelled autologous leucocyte scintigraphy

European journal of nuclear medicine and molecular imaging, 2002-01, Vol.29 (1), p.53-60

2002

Link zum Volltext

Verfügbarkeit prüfen

Defect and light induced absorption, luminescence and dielectric properties in sbn:cerium

Ferroelectrics, 1996-01, Vol.185 (1), p.289-292

1996

Link zum Volltext

Verfügbarkeit prüfen

Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy

European journal of nuclear medicine and molecular imaging, 2002-01, Vol.29 (1), p.53-60

2002

Link zum Volltext

Verfügbarkeit prüfen

TCTUs zur Differenzierung einer autoimmunen Hyperthyreose: In-vivo-Quantifizierung funktionell intakter Natrium-Iodid-Symporter

Schilddrüse 2001, 2002, p.139-148

Originally published 2002, 2002

Link zum Volltext

Verfügbarkeit prüfen

Chronic bacterial osteomyelitis: prospective comparison of 18F-FDG imaging with a dual-head coincidence camera and 111In-labelled autologous leucocyte scintigraphy

European journal of nuclear medicine, 2002, Vol.29 (1), p.53-60

2002

Link zum Volltext

Verfügbarkeit prüfen

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.2099-2111

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Clinical Trial of Sequential Neoadjuvant Chemotherapy With Ifosfamide, Doxorubicin, and Gemcitabine Followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results

Cancer, 2013-02, Vol.119 (3), p.540-547

2013

Link zum Volltext

Verfügbarkeit prüfen

Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience

The Journal of urology, 2003-04, Vol.169 (4), p.1295-1298

2003

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1mg/kg + ipilimumab 3mg/kg expansion from CheckMate 032

Annals of oncology, 2018-10, Vol.29, p.viii725-viii725

2018

Link zum Volltext

Verfügbarkeit prüfen

EVIDENCE SUPPORTING PREOPERATIVE CHEMOTHERAPY FOR SMALL CELL CARCINOMA OF THE BLADDER: A RETROSPECTIVE REVIEW OF THE M. D. ANDERSON CANCER EXPERIENCE

The Journal of urology, 2004-08, Vol.172 (2), p.481-484

2004

Link zum Volltext

Verfügbarkeit prüfen

83P Evaluation of concordance between PD-L1 immunohistochemistry 28-8 and 22C3 pharmDx assays in metastatic urothelial carcinoma (mUC) in PIVOT-10

Annals of oncology, 2021-09, Vol.32, p.S392-S393

2021

Link zum Volltext

Verfügbarkeit prüfen

749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032

Annals of oncology, 2020-09, Vol.31, p.S582-S583

2020

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032

Annals of oncology, 2018-10, Vol.29, p.viii725

2018

Link zum Volltext

Verfügbarkeit prüfen

Is There a Role for Surgery in the Management of Metastatic Urothelial Cancer? The M. D. Anderson Experience

The Journal of urology, 2004, Vol.171 (1), p.145-148

2004

Link zum Volltext

Verfügbarkeit prüfen

Bladder Cancer, Version 3.2024

Journal of the National Comprehensive Cancer Network, 2024-05, Vol.22 (4), p.216

2024

Link zum Volltext

Verfügbarkeit prüfen

A newly discovered oxidant defence system and its involvement in the development of Aurelia aurita (Scyphozoa, Cnidaria): reactive oxygen species and elemental iodine control medusa formation

The International journal of developmental biology, 2005, Vol.49 (8), p.969

2005

Link zum Volltext

Verfügbarkeit prüfen

LBA32Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase III trial of fluorouracil, interferon alfa-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

Journal of clinical oncology, 2002-03, Vol.20 (5), p.1361-1367

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(24)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(14)
Male
(12)
Female
(11)
Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Aged
(9)
Middle Aged
(9)
Adult
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Retrospective Studies
(8)
Neoplasm Staging
(5)
Aged, 80 And Over
(4)
Nephrology. Urinary Tract Diseases
(4)
Radiology, Nuclear Medicine & Medical Imaging
(4)
Surgery
(4)
Urinary Bladder Neoplasms - Pathology
(4)
Urinary Bladder Neoplasms - Surgery
(4)
Bladder Neoplasms
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnosis and follow up of aortitis in the elderly

Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter

Expression of the sodium iodide symporter in differentiated thyroid cancer: clinical evidence

Quantitative thyroid scintigraphy for the differentiation of Graves' disease and hyperthyroid autoimmune thyroiditis

Improvement of tomographic reconstruction in bone SPECT

F-18-FDG hybrid camera PET in patients with postoperative fever

Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma

Chronic bacterial osteomyelitis: prospective comparison of 18F-FDG imaging with a dual-head coincidence camera and 111In-labelled autologous leucocyte scintigraphy

Defect and light induced absorption, luminescence and dielectric properties in sbn:cerium

Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy

TCTUs zur Differenzierung einer autoimmunen Hyperthyreose: In-vivo-Quantifizierung funktionell intakter Natrium-Iodid-Symporter

Chronic bacterial osteomyelitis: prospective comparison of 18F-FDG imaging with a dual-head coincidence camera and 111In-labelled autologous leucocyte scintigraphy

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

A Phase 2 Clinical Trial of Sequential Neoadjuvant Chemotherapy With Ifosfamide, Doxorubicin, and Gemcitabine Followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results

Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience

Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1mg/kg + ipilimumab 3mg/kg expansion from CheckMate 032

EVIDENCE SUPPORTING PREOPERATIVE CHEMOTHERAPY FOR SMALL CELL CARCINOMA OF THE BLADDER: A RETROSPECTIVE REVIEW OF THE M. D. ANDERSON CANCER EXPERIENCE

83P Evaluation of concordance between PD-L1 immunohistochemistry 28-8 and 22C3 pharmDx assays in metastatic urothelial carcinoma (mUC) in PIVOT-10

749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032

Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032

Is There a Role for Surgery in the Management of Metastatic Urothelial Cancer? The M. D. Anderson Experience

Bladder Cancer, Version 3.2024

A newly discovered oxidant defence system and its involvement in the development of Aurelia aurita (Scyphozoa, Cnidaria): reactive oxygen species and elemental iodine control medusa formation

LBA32Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032

Phase III trial of fluorouracil, interferon alfa-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

Suchergebnisse filtern